Skip to main content

G7 22 (Theophylline Extended-Release 450 mg)

Pill with imprint G7 22 is White, Capsule-shape and has been identified as Theophylline Extended-Release 450 mg. It is supplied by Glenmark Pharmaceuticals Inc.

Theophylline is used in the treatment of apnea of prematurity; asthma, maintenance; asthma, acute and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 450 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for G7 22

Theophylline Extended-Release

Imprint
G7 22
Strength
450 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Methylxanthines
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Glenmark Pharmaceuticals Inc.
National Drug Code (NDC)
68462-0722

Get help with Imprint Code FAQs.

Related images for "G7 22"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.